H.R. 9969, Consumer Protection & Transparency Mandate. Quorum's AI analysis reads it as a net benefit — and names who gains.
H.R. 9969 · Net good
What it does
This bill directs the Federal Trade Commission to investigate whether manufacturers of preterm infant formula are using unfair or deceptive advertising—specifically, whether they are hiding information about health risks or downplaying the benefits of human milk-based fortifiers compared to bovine (cow's milk) fortifiers. Based on the investigation, the FTC must issue regulations within 18 months prohibiting such deceptive practices.
The analysis names Manufacturers of human milk-based fortifiers — and 2 more groups — among the beneficiaries.
The trade-off
The bill's 'Sense of Congress' section (Section 2) explicitly states that 'no manufacturer of preterm infant formula or related products should be permitted to limit, evade, or otherwise diminish the ability of families to pursue legal recourse.' This language may be interpreted as a directive to the FTC to scrutinize or prohibit arbitration clauses, liability waivers, and class-action bans in pro
Transparency scores 85%, with a medium warning level and no provisions unrelated to the bill's subject.
Who is behind it
Filed by Chris Pappas. Cosponsored by Madeleine Dean and Rosa DeLauro.